Hemoglobin and Iron Metabolism — MCQs

Hemoglobin and Iron Metabolism Indian Medical PG Practice Questions and MCQs

Question 171: Iron is present in all of the following compounds except:

A. Myoglobin
B. Cytochrome
C. Catalase
D. Pyruvate Kinase (Correct Answer)

Explanation: **Explanation:** The correct answer is **Pyruvate Kinase**. Iron is a vital trace element primarily found in the body as part of **Heme-containing proteins** or **Iron-sulfur (Fe-S) cluster proteins**. **1. Why Pyruvate Kinase is the correct answer:** Pyruvate Kinase is a key glycolytic enzyme that catalyzes the conversion of phosphoenolpyruvate (PEP) to pyruvate. Unlike heme-enzymes, Pyruvate Kinase requires **Potassium (K⁺)** and **Magnesium (Mg²⁺)** (or Manganese) as cofactors for its catalytic activity. It does not contain iron in its structure. **2. Analysis of incorrect options:** * **Myoglobin:** This is a monomeric heme protein found in muscle tissue. It contains a single heme group with an iron atom in the ferrous ($Fe^{2+}$) state, responsible for oxygen storage. * **Cytochromes:** These are heme-containing proteins (e.g., Cytochrome c, Cytochrome P450) essential for the Electron Transport Chain (ETC) and drug metabolism. They utilize the reversible oxidation-reduction of iron ($Fe^{2+} \leftrightarrow Fe^{3+}$) to transport electrons. * **Catalase:** This is a major antioxidant enzyme that protects cells from oxidative damage by decomposing hydrogen peroxide. It is a tetrameric protein containing four heme groups with central iron atoms. **High-Yield Clinical Pearls for NEET-PG:** * **Heme-containing enzymes:** Hemoglobin, Myoglobin, Cytochromes, Catalase, Peroxidase, and Tryptophan pyrrolase. * **Non-heme iron proteins:** Ferritin (storage), Transferrin (transport), and Succinate dehydrogenase (Fe-S cluster). * **Pyruvate Kinase Deficiency:** The most common enzyme deficiency in the glycolytic pathway, leading to **Chronic Non-spherocytic Hemolytic Anemia** due to ATP depletion in RBCs.

Question 172: In hemoglobin, iron is bound to which amino acid residue?

A. Histidine (Correct Answer)
B. Leucine
C. Isoleucine
D. Valine

Explanation: In hemoglobin, the iron ($Fe^{2+}$) atom is coordinated by six ligands. Four of these are the nitrogen atoms of the porphyrin ring. The fifth coordination site is occupied by the **imidazole ring of a Histidine residue**, specifically the **Proximal Histidine (F8)**. ### Why Histidine is Correct: * **Proximal Histidine (His F8):** This residue binds directly to the iron atom, anchoring the heme group to the globin chain. * **Distal Histidine (His E7):** While it does not bind directly to iron, it stabilizes the oxygen-binding site and helps prevent the toxic binding of Carbon Monoxide (CO) by forcing it into a bent conformation. * **Coordination:** The nitrogen atom in the imidazole side chain of histidine has a high affinity for transition metals like iron, making it essential for the reversible binding of oxygen. ### Why Other Options are Incorrect: * **Leucine, Isoleucine, and Valine:** These are non-polar, branched-chain amino acids. While they contribute to the hydrophobic pocket that protects the heme group from being oxidized (preventing the formation of Methemoglobin), they lack the functional side chains (like the imidazole group) required to form a coordinate covalent bond with iron. ### High-Yield Clinical Pearls for NEET-PG: * **T-state vs. R-state:** When oxygen binds, the iron atom moves into the plane of the porphyrin ring, pulling the Proximal Histidine with it. This triggers the conformational change from the T (Tense/Deoxygenated) state to the R (Relaxed/Oxygenated) state. * **Methemoglobinemia:** If iron is oxidized from the ferrous ($Fe^{2+}$) to the ferric ($Fe^{3+}$) state, it can no longer bind oxygen. * **M-Hemoglobin:** A mutation where the proximal or distal histidine is replaced by **Tyrosine**, leading to permanent iron oxidation and cyanosis.

Question 173: In heme synthesis, which of the following enzymes is inhibited by lead?

A. Xanthine oxidase
B. ALA dehydratase (Correct Answer)
C. ALA synthase
D. Uroporphyrin synthase

Explanation: **Explanation:** Heme synthesis is a multi-step process occurring in both the mitochondria and cytosol. Lead poisoning (plumbism) primarily affects this pathway by inhibiting two key enzymes: **ALA dehydratase** (also known as Porphobilinogen synthase) and **Ferrochelatase**. **Why ALA Dehydratase is correct:** ALA dehydratase is a zinc-containing enzyme that catalyzes the condensation of two molecules of delta-aminolevulinic acid (ALA) to form porphobilinogen (PBG). Lead displaces the zinc atom from the enzyme's active site, rendering it inactive. This leads to an accumulation of ALA in the blood and urine, which is a hallmark of lead toxicity. **Analysis of incorrect options:** * **Xanthine oxidase:** This enzyme is involved in purine catabolism (converting hypoxanthine to xanthine and then to uric acid). It is inhibited by Allopurinol, not lead. * **ALA synthase:** This is the rate-limiting enzyme of heme synthesis. It is inhibited by the end-product, **Heme** (feedback inhibition), and certain drugs, but it is not a direct target of lead. * **Uroporphyrin synthase:** Also known as PBG deaminase (HMB synthase). Deficiency of this enzyme leads to Acute Intermittent Porphyria (AIP). It is not inhibited by lead. **Clinical Pearls for NEET-PG:** * **Lead Poisoning Triad:** Microcytic hypochromic anemia, **Basophilic stippling** of RBCs (due to inhibition of pyrimidine 5'-nucleotidase), and elevated urinary ALA levels. * **Ferrochelatase:** The second enzyme inhibited by lead; it normally incorporates iron into Protoporphyrin IX. Its inhibition leads to elevated **Zinc Protoporphyrin** levels. * **Symptoms:** "LEAD" mnemonic – **L**ines on gingiva (Burton lines), **E**ncephalopathy/Erythrocyte stippling, **A**bdominal colic/Anemia, **D**rop (wrist/foot drop).

Question 174: What is the half-life of the haptoglobin complex?

A. 5 days
B. 3 days
C. 10 days
D. 10 minutes (Correct Answer)

Explanation: **Explanation:** **Haptoglobin** is an acute-phase reactant protein synthesized by the liver. Its primary physiological role is to bind free hemoglobin (Hb) released into the plasma during intravascular hemolysis. 1. **Why 10 minutes is correct:** While free haptoglobin has a circulating half-life of approximately **5 days**, the **Haptoglobin-Hemoglobin (Hp-Hb) complex** is cleared extremely rapidly from the circulation. Once the complex forms, it is recognized by **CD163 receptors** on macrophages (primarily in the spleen and liver). This receptor-mediated endocytosis is highly efficient, resulting in a half-life of about **10 to 20 minutes**. This rapid clearance prevents hemoglobin-induced oxidative tissue damage and prevents the loss of iron through the kidneys (preventing hemoglobinuria). 2. **Why other options are incorrect:** * **5 days (Option A):** This is the half-life of **unbound (free) haptoglobin**. In states of hemolysis, haptoglobin levels drop to near zero because it is consumed faster than it is produced. * **3 days / 10 days (Options B & C):** These values do not correspond to haptoglobin kinetics. Most plasma proteins have half-lives measured in days, but the Hp-Hb complex is a notable exception due to its rapid "suicide" clearance mechanism. **High-Yield Clinical Pearls for NEET-PG:** * **Marker of Hemolysis:** A **decreased serum haptoglobin level** is the most sensitive laboratory indicator of **intravascular hemolysis**. * **Size Exclusion:** The Hp-Hb complex is too large to be filtered by the renal glomeruli; thus, haptoglobin protects the kidneys from iron-mediated tubular damage. * **Acute Phase Reactant:** Haptoglobin levels may be falsely normal or elevated during inflammation, even if hemolysis is present. * **Hemopexin:** If haptoglobin is saturated, free heme is bound by **Hemopexin**. If that is also saturated, heme binds to albumin to form **methemalbumin**.

Question 175: Copper is mainly transported by?

A. Ceruloplasmin (Correct Answer)
B. Albumin
C. Haptoglobin
D. Globulin

Explanation: **Explanation:** **Ceruloplasmin (Option A)** is the correct answer. It is an alpha-2 globulin synthesized in the liver that carries approximately **90-95% of the total copper** in the plasma. Each molecule of ceruloplasmin binds 6 to 8 atoms of copper tightly. Beyond transport, it functions as a **ferroxidase enzyme**, converting ferrous iron ($Fe^{2+}$) to ferric iron ($Fe^{3+}$), which is essential for iron binding to transferrin and subsequent utilization. **Analysis of Incorrect Options:** * **Albumin (Option B):** While albumin carries about 5-10% of plasma copper, it is considered the "loose" or rapid-exchange transporter. It primarily transports copper from the intestine to the liver, but ceruloplasmin remains the major systemic transporter. * **Haptoglobin (Option C):** This protein specifically binds to **free hemoglobin** released from erythrocytes to prevent oxidative damage and iron loss through the kidneys. * **Globulin (Option D):** This is a broad category of plasma proteins. While ceruloplasmin is a type of alpha-globulin, "Globulin" is too non-specific as an answer. **High-Yield Clinical Pearls for NEET-PG:** * **Wilson’s Disease:** Characterized by a deficiency of P-type ATPase (ATP7B), leading to **decreased serum ceruloplasmin** levels and copper deposition in the liver (cirrhosis) and basal ganglia (Kayser-Fleischer rings). * **Menkes Disease:** An X-linked recessive disorder (ATP7A mutation) resulting in impaired copper absorption, leading to "kinky hair" and growth retardation. * **Acute Phase Reactant:** Ceruloplasmin levels increase during inflammation, infection, and pregnancy.

Question 176: Urobilinogen is formed in the:

A. Liver
B. Kidney
C. Intestine (Correct Answer)
D. Spleen

Explanation: ### Explanation **Correct Answer: C. Intestine** The formation of **urobilinogen** is a key step in heme catabolism that occurs exclusively in the **intestine**. 1. **Mechanism:** Conjugated bilirubin (bilirubin diglucuronide) is excreted from the liver into the bile and enters the duodenum. In the distal ileum and colon, **intestinal bacteria** (anaerobes) deconjugate the bilirubin and reduce it into colorless compounds known as **urobilinogens**. 2. **Fate:** Most urobilinogen is oxidized to stercobilin (giving feces its brown color). About 20% is reabsorbed into the enterohepatic circulation; of this, a small fraction escapes hepatic uptake and is excreted by the kidneys as urobilin. **Why other options are incorrect:** * **A. Liver:** The liver is responsible for the **conjugation** of bilirubin (via the enzyme UDP-glucuronosyltransferase) to make it water-soluble, but it does not produce urobilinogen. * **B. Kidney:** The kidney filters a small amount of urobilinogen from the blood to excrete it as **urobilin**, but it is not the site of formation. * **C. Spleen:** The spleen is the primary site of **heme breakdown** where senescent RBCs are destroyed to form unconjugated bilirubin (via heme oxygenase and biliverdin reductase). **High-Yield Clinical Pearls for NEET-PG:** * **Biliary Obstruction:** In complete obstructive jaundice, bilirubin cannot reach the intestine; therefore, **urobilinogen will be absent** in both urine and feces (leading to clay-colored stools). * **Hemolytic Jaundice:** Increased heme breakdown leads to high levels of conjugated bilirubin reaching the gut, resulting in **increased urinary urobilinogen**. * **Van den Bergh Reaction:** Remember that conjugated bilirubin gives a **direct** reaction, while unconjugated bilirubin gives an **indirect** reaction.

Question 177: Lead inhibits which enzymes in the heme synthesis pathway?

A. Aminolevulinate synthase
B. Ferrochelatase and 6-ALA dehydratase (Correct Answer)
C. Porphobilinogen deaminase
D. Uroporphyrinogen decarboxylase

Explanation: **Explanation:** Lead poisoning (Plumbism) interferes with heme biosynthesis by inhibiting enzymes that contain **sulfhydryl (-SH) groups**. **1. Why Option B is Correct:** Lead specifically targets two key enzymes in the pathway: * **$\delta$-Aminolevulinate (ALA) Dehydratase:** This cytosolic enzyme converts ALA to Porphobilinogen. Lead displaces the zinc cofactor required for its activity, leading to an accumulation of **$\delta$-ALA** in the blood and urine. * **Ferrochelatase:** This mitochondrial enzyme catalyzes the final step—inserting ferrous iron ($Fe^{2+}$) into Protoporphyrin IX to form Heme. Lead inhibits this enzyme, causing an accumulation of **Protoporphyrin IX** (often measured as Zinc Protoporphyrin). **2. Analysis of Incorrect Options:** * **Option A (ALA Synthase):** This is the rate-limiting enzyme of heme synthesis. It is inhibited by the end-product, Heme (feedback inhibition), not directly by lead. * **Option C (PBG Deaminase):** Deficiency of this enzyme causes **Acute Intermittent Porphyria (AIP)**. * **Option D (Uroporphyrinogen Decarboxylase):** Deficiency of this enzyme leads to **Porphyria Cutanea Tarda (PCT)**, the most common porphyria. **3. Clinical Pearls for NEET-PG:** * **Microcytic Hypochromic Anemia:** Resulting from decreased heme production. * **Basophilic Stippling:** A classic peripheral smear finding in lead poisoning due to the inhibition of pyrimidine 5'-nucleotidase, causing RNA degradation products to aggregate. * **Burton’s Line:** A bluish-purple line on the gums. * **Radiology:** "Lead lines" (increased metaphyseal density) seen in the long bones of children. * **Treatment:** Chelation therapy with **Succimer** (oral, first-line in children) or **CaNa₂EDTA/Dimercaprol**.

Question 178: Vitamin K dependent clotting factors include all EXCEPT:

A. Factor VII
B. Factor VIII (Correct Answer)
C. Prothrombin
D. Factor IX

Explanation: **Explanation:** The synthesis of certain coagulation factors requires **Vitamin K** as a vital cofactor for the post-translational modification of glutamic acid residues. This process, mediated by the enzyme **gamma-glutamyl carboxylase**, converts glutamate residues into gamma-carboxyglutamate (Gla). This modification allows these factors to bind calcium ions and attach to phospholipid surfaces, which is essential for the clotting cascade. * **Why Factor VIII is the Correct Answer:** Factor VIII is a glycoprotein cofactor synthesized primarily in the sinusoidal endothelial cells of the liver and extrahepatic sites. Unlike the Vitamin K-dependent factors, it does not undergo gamma-carboxylation. It circulates in the plasma bound to von Willebrand Factor (vWF). * **Why the other options are incorrect:** Factors **II (Prothrombin)**, **VII**, **IX**, and **X** are the four classic Vitamin K-dependent procoagulant factors. Therefore, options A, C, and D are incorrect as they all require Vitamin K for functional synthesis. **High-Yield NEET-PG Pearls:** 1. **Mnemonic:** Remember the Vitamin K-dependent factors as "**1972**" (Factors **10, 9, 7, and 2**) plus **Protein C and Protein S** (anticoagulants). 2. **Warfarin Mechanism:** Warfarin acts as a Vitamin K antagonist by inhibiting **Vitamin K epoxide reductase (VKOR)**, preventing the recycling of Vitamin K. 3. **Half-life:** Factor VII has the shortest half-life among these factors, which is why the Prothrombin Time (PT/INR) is the first to rise during Vitamin K deficiency or Warfarin therapy. 4. **Clinical Correlation:** Vitamin K deficiency leads to hemorrhagic disease of the newborn because Vitamin K crosses the placenta poorly and breast milk is a poor source.

Question 179: Acquired porphyria is due to which of the following?

A. Mercury toxicity
B. Lead poisoning (Correct Answer)
C. Copper deficiency
D. Selenium toxicity

Explanation: **Explanation:** Acquired porphyria (also known as secondary porphyrinuria) occurs when external toxins interfere with the heme biosynthesis pathway, mimicking the clinical and biochemical features of genetic porphyrias. **1. Why Lead Poisoning is correct:** Lead is a potent inhibitor of two key enzymes in the heme synthesis pathway: * **ALA Dehydratase (δ-aminolevulinic acid dehydratase):** Lead displaces the zinc cofactor, leading to an accumulation of ALA. * **Ferrochelatase:** This enzyme catalyzes the insertion of ferrous iron into protoporphyrin IX. Lead inhibits this step, causing an accumulation of **Protoporphyrin IX** in erythrocytes (Zinc-protoporphyrin). The inhibition of these enzymes results in decreased heme production and increased urinary excretion of ALA and coproporphyrin III, clinically presenting as abdominal pain and neurological symptoms similar to Acute Intermittent Porphyria. **2. Why other options are incorrect:** * **Mercury toxicity:** Primarily affects the central nervous system and kidneys (nephrotic syndrome) but does not specifically target the heme synthesis enzymes to cause porphyria. * **Copper deficiency:** Copper is essential for iron transport (via ceruloplasmin) and is a cofactor for Cytochrome c oxidase. Deficiency leads to **Sideroblastic anemia** (due to defective iron utilization), not porphyria. * **Selenium toxicity:** Known as selenosis, it causes hair loss, nail changes, and peripheral neuropathy, but has no direct role in porphyrin metabolism. **High-Yield Clinical Pearls for NEET-PG:** * **Basophilic Stippling:** A classic peripheral smear finding in lead poisoning due to the inhibition of pyrimidine 5'-nucleotidase. * **Burton’s Line:** A bluish-purple line on the gums indicative of chronic lead exposure. * **Treatment:** Chelation therapy with **Succimer** (oral), **Ca-EDTA**, or **Dimercaprol (BAL)**. * **Diagnostic Marker:** Elevated **Zinc Protoporphyrin (ZPP)** is a sensitive screening marker for chronic lead poisoning.

Question 180: Which of the following statements about hemochromatosis is true?

A. Shows complete penetrance
B. Inherited as an autosomal recessive disorder (Correct Answer)
C. Phlebotomy is curative
D. More common in females

Explanation: **Explanation:** **Hereditary Hemochromatosis (HH)** is a classic metabolic disorder characterized by excessive intestinal iron absorption leading to iron overload in various organs (liver, heart, pancreas). 1. **Why Option B is Correct:** Hereditary Hemochromatosis is primarily an **autosomal recessive** disorder. The most common mutation involves the **HFE gene** (C282Y mutation on Chromosome 6). This mutation leads to a deficiency in **Hepcidin**, the master regulator of iron. Low hepcidin levels result in the over-expression of ferroportin, causing uncontrolled iron release into the plasma. 2. **Why Other Options are Incorrect:** * **Option A:** It shows **incomplete penetrance**. While many individuals carry the homozygous mutation, only a small fraction (especially in females) develops the full clinical phenotype of organ damage. * **Option C:** While phlebotomy is the **treatment of choice** and life-saving, it is not "curative" in a genetic sense. It manages the iron levels but does not correct the underlying genetic defect or reverse advanced cirrhosis. * **Option D:** It is significantly **more common in males** (M:F ratio approx. 5:1). Females are protected during their reproductive years due to physiological iron loss through menstruation and pregnancy. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad (Bronze Diabetes):** Skin hyperpigmentation, Diabetes mellitus, and Cirrhosis. * **Diagnosis:** Best initial test is **Transferrin Saturation** (>45%); Gold standard is **HFE gene analysis**. * **MRI:** Shows "signal dropout" in the liver due to paramagnetic effects of iron. * **Complication:** Significantly increased risk of **Hepatocellular Carcinoma (HCC)**.

Practice by Chapter

Hemoglobin Structure and Function

Practice Questions

Oxygen Transport and Oxygen-Hemoglobin Dissociation Curve

Practice Questions

Hemoglobin Variants and Hemoglobinopathies

Practice Questions

Thalassemias

Practice Questions

Methemoglobin and Abnormal Hemoglobins

Practice Questions

Hemoglobin Synthesis

Practice Questions

Heme Synthesis and Porphyrias

Practice Questions

Iron Absorption and Transport

Practice Questions

Iron Storage and Recycling

Practice Questions

Disorders of Iron Metabolism

Practice Questions

Anemia: Biochemical Aspects

Practice Questions

Biochemistry of Hemostasis

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free